The most common type of mutation not related to RET mutation is the HRASQ61R HRAS mutation occurring in up to 11% of sporadic MTC cases, which is thought to be associated with an intermediate level of aggressiveness in terms of tumor progression [15,16]. This evidence concerns the gene RET and medullary thyroid gland carcinoma.